Last update 23 Jul 2025

Naproxen Sodium/Pseudoephedrine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Naproxen Sodium and Pseudoephedrine Hydrochloride, 萘普生钠/盐酸伪麻黄碱, Aleve-D
+ [2]
Target
COXs x α-adrenergic receptor
Action
inhibitors, agonists
Mechanism
COX inhibitors(Cyclooxygenases inhibitors), α-adrenergic receptor agonists(Alpha adrenergic receptor agonists)
Therapeutic Areas
Infectious DiseasesNervous System DiseasesOtorhinolaryngologic Diseases+ [2]
Active Indication
Common ColdFeverNasal Obstruction+ [1]
Inactive Indication-
Originator Organization
Bayer AGBayer AG
Active Organization
Harbin Pharmaceutical Group Holding Co., Ltd.Harbin Pharmaceutical Group Holding Co., Ltd.Harbin Pharmaceutical Group Co., Ltd.Harbin Pharmaceutical Group Co., Ltd.
Inactive Organization
Bayer Healthcare LLC
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (29 Nov 1999),
Common Cold
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC10H16ClNO
InChIKeyBALXUFOVQVENIU-KXNXZCPBSA-N
CAS Registry345-78-8
View All Structures (2)

Related

100 Clinical Results associated with Naproxen Sodium/Pseudoephedrine Hydrochloride
Login to view more data
100 Translational Medicine associated with Naproxen Sodium/Pseudoephedrine Hydrochloride
Login to view more data
100 Patents (Medical) associated with Naproxen Sodium/Pseudoephedrine Hydrochloride
Login to view more data
100 Deals associated with Naproxen Sodium/Pseudoephedrine Hydrochloride
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
R01BA52
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Fever
China
Harbin Pharmaceutical Group Co., Ltd.Harbin Pharmaceutical Group Co., Ltd.
21 Jan 2004
Nasal Obstruction
China
Harbin Pharmaceutical Group Holding Co., Ltd.Harbin Pharmaceutical Group Holding Co., Ltd.
21 Jan 2004
Pain
China
Harbin Pharmaceutical Group Holding Co., Ltd.Harbin Pharmaceutical Group Holding Co., Ltd.
21 Jan 2004
Common Cold
United States
Bayer Healthcare LLC
29 Nov 1999
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free